Cinemark Holdings, Inc. (CNK)
Quantitative Summary
DeterministicCNK trades at 27.0x earnings, roughly in line with its sector average of 32.1x. Financial health is average: Piotroski 4/9, Altman Z 1.3.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of Cinemark Holdings reveal a capital allocation challenge, evidenced by an ROIC-WACC spread of -1.9%, indicating the firm is currently generating returns below its cost of equity. This underperformance persists despite robust operational leverage in pricing power, as reflected by a healthy 64.1% gross margin; however, these margins are compressed into a narrow net income stream yielding only a 4.4% net margin and sluggish revenue growth of 2.1%. The DuPont decomposition suggests that while top-line efficiency remains intact via high gross spreads, the bottom line suffers from either elevated operating costs or significant leverage drag, though the Altman Z-Score of 1.3 signals potential distress risks rather than insolvency. Creditworthiness appears fragile given this low Z-score, yet financial statement integrity seems preserved with a strong Beneish M-Score of -2.61 and a moderate Piotroski F-Score of 4/9, suggesting earnings quality is not being manipulated despite the weak growth trajectory.
Valuation metrics present a mixed picture where the current P/E multiple of 27.0x trades at a discount to the sector average of 37.7x, potentially reflecting market skepticism regarding its capital efficiency and growth ceiling rather than pure undervaluation. A DCF analysis implies a fair value of $40, yet this target must be weighed against the structural headwinds highlighted by the negative spread between return on invested capital and the weighted average cost of capital. The market appears to be pricing in limited upside given the tepid revenue expansion, while the current multiple may offer some buffer if management can eventually turn the ROIC-WACC dynamic positive through improved asset utilization or margin expansion.
The risk/reward profile is skewed by conflicting signals: the low Altman Z-Score introduces solvency concerns that contrast with a clean Beneish M-Score and moderate Piotroski score, creating uncertainty about future cash flow stability versus accounting reliability. Investors must weigh whether the current valuation discount adequately compensates for the capital destruction evident in the negative ROIC spread or if it represents an opportunity to buy into a turnaround story pending operational improvements.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 6.9% | 8.9% | 10.9% |
|---|---|---|---|
| 2% | $53 | $34 | $23 |
| 3% | $67 | $40 | $26 |
| 4% | $91 | $48 | $31 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=8.9%, terminal growth 3%. Fair value $40 (+0.0%). Not investment advice.
Valuation Context
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like SLYG or VOX, the fund manager is mechanically forced to buy or sell CNK shares regardless of Cinemark Holdings, Inc.'s individual fundamentals. We estimate $77M of passive capital is structurally linked to CNK through 7 tracked ETFs. Passive flows have a limited but growing influence on CNK's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 7 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Cinemark Holdings, Inc. to visualize passive redemption contagion across ETFs and collateral stocks.
If Cinemark Holdings, Inc. (CNK) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Facebook Inc. Class A (META) as the most exposed collateral stock, sharing 1 ETFs with CNK. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 7 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
CNK Ownership Dynamics
ETFs with Highest CNK Exposure
Float lock-up computed from 7 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
CNK Capital Efficiency
How efficiently does Cinemark Holdings, Inc. convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
Cinemark Holdings, Inc. converts 34% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 66% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-1.9%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-13 | 18,584 | $26.28 | $488,387.52 |
| 2026-05-07 | 14 | $27.73 | $388.22 |
| 2026-05-05 | 3,689 | $27.26 | $100,562.14 |
| 2026-04-30 | 33 | $29.01 | $957.33 |
| 2026-04-20 | 1,872 | $30.01 | $56,178.72 |
| 2026-04-14 | 38 | $30.37 | $1,154.06 |
| 2026-03-11 | 100 | $26.66 | $2,666 |
| 2026-03-10 | 33 | $27.07 | $893.31 |
| 2026-03-03 | 2,397 | $28.55 | $68,434.35 |
| 2026-02-25 | 163 | $25.66 | $4,182.58 |
| 2026-02-20 | 25,614 | $26.36 | $675,185.04 |
| 2026-02-19 | 25,635 | $26.41 | $677,020.35 |
| 2026-02-11 | 138 | $25.75 | $3,553.5 |
| 2026-02-09 | 55 | $25.77 | $1,417.35 |
| 2026-02-03 | 1,471 | $24.67 | $36,289.57 |
| 2026-01-23 | 1,211 | $24.12 | $29,209.32 |
| 2026-01-21 | 34,849 | $24.55 | $855,542.95 |
| 2026-01-20 | 301,124 | $23.93 | $7.2M |
| 2026-01-12 | 12 | $22.47 | $269.64 |
| 2026-01-05 | 688 | $23.53 | $16,188.64 |
| 2026-01-02 | 984 | $23.24 | $22,868.16 |
| 2025-12-29 | 670 | $22.86 | $15,316.2 |
| 2025-12-23 | 2,497 | $22.45 | $56,057.65 |
| 2025-12-22 | 92,763 | $22.27 | $2.1M |
| 2025-12-17 | 5 | $23.81 | $119.05 |
| 2025-12-15 | 5 | $24.65 | $123.25 |
| 2025-12-10 | 4,484 | $24.52 | $109,947.68 |
| 2025-11-26 | 791,532 | $27.99 | $22.2M |
| 2025-11-20 | 382 | $30.10 | $11,498.2 |
| 2025-11-18 | 3,059 | $29.59 | $90,515.81 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare CNK to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.